These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 14668879)

  • 21. Second-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2015 Aug; 33(8):883. PubMed ID: 26252149
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyseq-Variagenics merger signals end of the line.
    Hodgson J
    Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
    [No Abstract]   [Full Text] [Related]  

  • 23. First-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2012 May; 30(5):467. PubMed ID: 22565977
    [No Abstract]   [Full Text] [Related]  

  • 24. Scientists and societies. An introduction to biotechnology.
    Anderson E
    Nature; 2004 Mar; 428(6980):350. PubMed ID: 15029204
    [No Abstract]   [Full Text] [Related]  

  • 25. High-tech, high society.
    Powell K
    Nature; 2003 Dec; 426(6967):720-1. PubMed ID: 14668880
    [No Abstract]   [Full Text] [Related]  

  • 26. Biotechnology. Sheep fail to produce golden fleece.
    Vogel G
    Science; 2003 Jun; 300(5628):2015-6. PubMed ID: 12829753
    [No Abstract]   [Full Text] [Related]  

  • 27. Virtual recruitment.
    Mills E
    Nat Biotechnol; 2002 Aug; 20(8):853. PubMed ID: 12148015
    [No Abstract]   [Full Text] [Related]  

  • 28. Millennium and Aventis in unique pact.
    Fletcher L
    Nat Biotechnol; 2000 Aug; 18(8):817. PubMed ID: 10932140
    [No Abstract]   [Full Text] [Related]  

  • 29. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 30. California dreaming: San Diego.
    Smaglik P
    Nature; 2003 Mar; 422(6928):240-1. PubMed ID: 12634799
    [No Abstract]   [Full Text] [Related]  

  • 31. Genentech makes its first-ever acquisition.
    Hollmer M
    Nat Biotechnol; 2007 Jan; 25(1):4-5. PubMed ID: 17211375
    [No Abstract]   [Full Text] [Related]  

  • 32. Translating science into business.
    Schuster S
    Nature; 2007 Mar; 446(7135):582. PubMed ID: 17421073
    [No Abstract]   [Full Text] [Related]  

  • 33. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 34. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 35. Building cooperation New York.
    Smaglik P
    Nature; 2002 Sep; 419(6905):4-5. PubMed ID: 12352990
    [No Abstract]   [Full Text] [Related]  

  • 36. Troubled UK biotech firm faces new probe.
    Masood E
    Nature; 1998 Apr; 392(6679):852. PubMed ID: 9582060
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 38. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 39. Big biotech buys iconic genetics firm.
    Baker M
    Nature; 2012 Dec; 492(7429):321. PubMed ID: 23257857
    [No Abstract]   [Full Text] [Related]  

  • 40. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.